Elucidating the Effect of hesperidin on Behavioral and biochemical markers of liver and kidney function in Sprague Dawley Rats

 

Pandian PaneerSelvam1,2, Usha Kumari1, Dharma Raj Tanimale1,2, Mohamed Asem1,2,

Sherly Deborah George3, Subramani Parasuraman4

1Unit of Physiology, Faculty of Medicine, AIMST University, Kedah, Malaysia.

2Clinical Skills Centre, Faculty of Medicine, AIMST University, Kedah, Malaysia.

3Department of Physiology, Faculty of Medicine, Manipal University College Malaysia, Melaka, Malaysia.

4Department of Pharmacology, Faculty of Pharmacy, AIMST University, Kedah, Malaysia.

*Corresponding Author E-mail: dr.pandianselvam@gmail.com

 

ABSTRACT:

Background: Hesperidin is a naturally occurring Bioflavonoid found in citrus fruits. It has anti-inflammatory, antioxidant, antihypertensive, antimicrobial, anti-carcinogenic and vasodilator activities. Hesperidin’s effect on normal behavioral is not clear. Hence the present study is aimed to elucidate the effects of hesperidin on behavioral and biochemical markers of liver and kidney function in Sprague Dawley (SD) rats. Method: Healthy, adult, male SD rats were used for the study. Animals were divided into 5 groups (n = 6) viz., Group I: Control, Group II: Vitamin C(200mg/kg), Group III: Hesperidin (25mg/kg), Group IV: Hesperidin (50mg/kg) and GroupV: Hesperidin (100mg/kg). The standard and test drugs were suspended in 0.5% w/v carboxymethyl cellulose and administered once daily through oral gavage for 28 consecutive days. Throughout the study changes in behavioral functions (locomotor activity, muscular strength, learning and memory) and body weight were monitored at regular intervals. Blood samples were collected from all the experimental rats and used for biochemical parameters analysis. Results: Vitamin C and hesperidin did not show any significant alterations in locomotion, grip strength, muscular strength and spatial memory when compared with normal control. Both vitamin C and hesperidin improved the normal anxiety behavior without affecting regular body weight gain and biochemical markers of liver and kidney function. Conclusion: The experimental rats administered with hesperidin at the dose levels of 25, 50and100 mg/kg did not show any changes in psychomotor behavior and significantly improved their alertness without affecting the biochemical markers of liver and kidney function.

 

KEYWORDS: Actophotometer, Citrus fruits, Forced swim test, Rotarod, Wire grip strength.

 

 


INTRODUCTION: 

Medicinal plants are commonly used as ingredients to prevent or treat diseases. The early documented records stating the usage of herbal medicine for both prevention and treatment date back to around 5,000 years in India and China.1

 

Plantextract and its phytoconstituents are commonly used for treating various diseases and disorders. The extracts of the plants and their phytoconstituents are proven for their biological activities.2 Flavonoids are one of the promising plant secondary metabolites of over 6000 different components that can be found almost in all plants which are also in-charge for the pigmentation of the fruits, is a ubiquitous group of polyphenolic substances.3 Epidemiological and animal studies have shown that citrus flavonoids influence various activities including antioxidant, anti-carcinogenic, anti-inflammatory activities and neuroprotective effects.4

Hesperidin is a naturally occurring bioflavonoid found in immature sour oranges, Citrus unshiu, Ponderosa lemon and C. mitis. Hesperidin hasanaglycon (hesperitinormethyleriodictyol) combined with rutinose[6-O-(-l-Rhamnopyranosyl)-D-glucopyranose] and/or [6-O-(-l-Rhamnosyl)-D-glucose], as a disaccharide component, in its structure and this makes hesperidin to be considered as -7-rutinoside of hesperetin.5 The bitter compound which is in the Citrusaurantium (bitterorange) is an isomer of hesperidin which is known as neohesperidin.4

 

Hesperidin has antimicrobial, antioxidant, antidiabetic, antihyperlipidemic, anticancer and antipsychotics and its effect on the normal physiological condition is not clear. Hence the present study is planned to investigate the dose-depended psychomotor behavior and biochemical changes in rodents.

 

MATERIALS AND METHODS:

Animals:

Healthy, adult, male Sprague Dawley (SD) rats weighing between 140–160 g was obtained from AIMST University’s Central Animal house. The rats were housed in large, spacious polyacrylic cages at an ambient room with a 12-hr-light/12-hr-dark cycle.  The rats were fed with a normal rodent pellet diet and water ad libitum. The study was carried out with prior ethical approval (AUAEC/FOM/2020/06) from AIMST University Human and Animal Ethics Committee, and the study was conducted according to the Animal Research Review Panel guidelines.

 

Effect of hesperidinon behavioral and biochemical markers of liver and kidney function:

A total of 30 rats were used for the study. The rats were divided into 5 groups (6 animals in each group) [n = 6/group] as follows:

Group I: Control

Group II: Vitamin C (200mg/kg)

Group III: Hesperidin (25mg/kg)

Group IV: Hesperidin (50mg/kg)

Group V: Hesperidin (100mg/kg)

The dose of vitamin C and hesperidin is selected from the literature.6,7Vitamin C is a known antioxidant. Neurodegenerative diseases typically involve high levels of oxidative stress and the antioxidant exhibited potential therapeutic roles against ischemic stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease.8In the present study, effect of hesperidin is compared with antioxidant. Both vitamin C and hesperidin had been suspended in 0.5% w/v carboxymethyl cellulose (CMC) and administered via oral gavage once daily for 28 consecutive days. The body weight of the rats was monitored at regular intervals. The effect of hesperidin on behavior (locomotor activity, grip strength, muscular strength, anxiolytic behavior, immunization time) was studied on pre-study day, day 7, 14, 21 and 28 of the experiment. At the end of the study, the blood sample was collected from the experimental rats through retro-orbital plexus puncture. The serum was separated from the blood sample and was used for biochemical analysis.

 

Body weight analysis:

Body weight variations were monitored throughout the study for all the experimental animals at regular intervals.

 

Behavioral analysis:

Effect of hesperidin on rodent locomotion, grip strength, muscular strength, anxiolytic behavior, and immunization time were studied using rodent activity cage (actophotometer), hanging wire grip test, rotarod test, elevated plus maze test and forced swim test, respectively.

 

Locomotor activity:

The locomotor activity of the animal was monitored using actophotometer. Individual rat activity was monitored for 10 minutes at room temperature. Each rat was given the respective drug and its activity score was evaluated and recorded after the interval of 15 min.9

 

Hanging wire grip test:

The hanging wire grip test was performed to evaluate the strength of the neuromuscular and the coordination of movement of an experimental animal. Two heavy-based retort stands were placed at a width of 55 cm, and a thread which is 1 mm thick was tied in between these two poles at 35cm of height. During the test, the thread was tightly attached to the frame to avoid vibration or unwanted displacement of the thread. The animal was placed in the center of the wire, and the latency to falling time was observed. A covering of the bedding material was set down to avoid trauma and injury to the animal when it falls.10

 

Muscular activities:

The muscle coordination test was done using the rotarod apparatus. The speed of the rod rotation was adjusted to 4 rpm/min at first and then was increased up to 20 rpm/min. Pre-training was done to the rats using the rotarod for the duration of 1–3 h prior to the testing. The training was incorporated by placing the rat on the rotating rod and measuring the latency to fall, up to a maximum of 120 s.11

 

Anxiolytic behavior effect:

Anxiolytic behavior was studied using rodent elevated plus maze. The elevated plus maze is made of two enclosed and open arms with 50 × 10 (L × W) dimensions and heights of 40 cm enclosed arms. The two enclosed and open arms were arranged opposite to each other, and the maze was elevated to 60 cm in height. Preceding the experiment, on the 7thand 14thday of the experiment, the rat was placed in the center of the maze, facing one of the enclosed arms and was monitored for the duration of 10 min. During the observation, the number of entries to each arm and the time spent in each arm were recorded. The elevated plus maze experiment was conducted inan environment which is sound free.12

 

Forced swim test:

The forced swim test is used to evaluate “depressive-like” states and behavioral despair. The training was done for 3 consecutive days, with four consecutive trials/day for each of the experimental rats with a time interval of 30 min.13 The water tank contained a round pool, filled with tap water (23°C–26°C), to the depth of 0.3–0.4 m. The rodent was then put into the tank upon which the time between the rodent stopped swimming and start sinking was recorded. The rodent was removed immediately as soon as it started to sink. The procedure was repeated for all the rodents. The water tank was then cleaned frequently to avoid microbial contaminations.14

 

Biochemical parameters analysis:

At the end of the study, about 1 mL of blood sample was collected through the retro-orbital plexus and the serum was separated by centrifuging at 3000 RPM for 20 min.15 Then, the separated serum sample was used for the estimation of alanine aminotransferase [ALT], aminotransferase [AST], alkaline phosphatase [ALP], creatinine and urea using the Reflotron Plus biochemical analyzer (Roche Diagnostics, Germany) with the help of commercially available Reflotron strips.

 

Statistical analysis:

All the data was expressed as mean ± standard error of the mean (SEM), and the statistical significance between the groups was tested using one-way analysis of variance followed by Tukey’s post-hoc test. P < 0.05 was considered statistically significant.

 

RESULTS:

Hesperidin (25, 50 and 100 mg/kg) and vitamin C administered animals did not show any significant changes in the bodyweight throughout the study when compared with the control animals (Figure – 1).

 

In behavioral analysis, hesperidin and vitamin C did not cause any significant changes in locomotor activity, grip strength, muscular strength and immobilization time when compared with the control (Figure – 2 - 5). The anxiolytic effect of hesperidin was studied using an elevated plus maze. In this, hesperidin 50 and 100 mg/kg showed significant reductions in time spent in closed arms and increased in time spent in open arms from day 21 and day 14 onwards, respectively when compared with the control. Vitamin C significantly reduced time spent in closed arms and increased the time spent in open arms from day 14 onwards compared with the control group (P<0.001). The results indicated that both hesperidin (50 and 100 mg/kg) and vitamin C administered animals had improved the normal anxiety behavior (Figure – 6 & 7).

 

In biochemical parameters analysis, both hesperidin and vitamin C did not cause any significant changes in AST, ALT, ALP, bilirubin, urea, and creatinine when compared with the control (Table - 1).

 

Figure 1: Effect of hesperidinon body weight of rats. All the values are expressed as mean± SEM (n =6).

 

Figure - 2:  Effect of hesperidinon locomotor activity of rats. All the values are expressed as mean ± SEM (n = 6).

 

Figure - 3: Effect of hesperidinon grip strength of rats. All the values are expressed as mean± SEM (n =6).

 

Figure - 4:  Effect of hesperidinon muscle coordination of rats. All the values are expressed as mean ± SEM (n =6).

 

Figure - 5:  Effect of hesperidinon immobilization time of rats. All the values are expressed as mean± SEM (n =6).

 

Text Box: cText Box: cText Box: cFigure – 6: Effect of hesperidin on anxiety (Time spend in elevated plus maze arms) of rats. Values are expressed as mean ± SEM(n=6).bP<0.01andcP<0.001compare with control (One-way ANOVA followed by Tukey post-hoc test)

 

Figure – 7: Effect of hesperidin on anxiety (Number of entries in elevated plus maze arms) of rats. All the values are expressed as mean± SEM (n =6).


 

Table – 1: Effect of hesperidin on biochemical parameters of rats

 

AST

(U/L)

ALT

(U/L)

ALP

(U/L)

Bilirubin

(mmol/L)

Urea

(mg/dL)

Creatinine

(mg/dL)

Control

124.83 ±

12.73

103.67 ±

13.74

46.17 ±

5.54

11.86 ±

1.16

36.50 ±

2.16

0.47 ± 0.02

VitaminC

(200mg/kg)

118.67 ±

12.12

104.67 ±

10.85

45.17 ±

5.68

11.60 ±

1.01

34.67 ±

2.30

0.45 ± 0.02

Hesperidin

(25mg/kg)

123.25 ±

6.89

94.48 ±

11.47

44.33 ±

5.31

11.93 ±

0.56

35.67 ±

3.45

0.50 ± 0.02

Hesperidin

(50mg/kg)

115.33 ±

7.31

106.45 ±

4.58

47.67 ±

3.83

11.58 ±

0.69

36.67 ±

2.51

0.48 ± 0.02

Hesperidin

(100mg/kg)

122.83 ±

9.65

97.10 ±

12.89

47.50 ±

6.67

11.67 ±

0.87

36.50 ±

3.04

0.47 ± 0.03

Values are expressed as mean ± SEM(n=6).

 


DISCUSSION:

In the present study, effect of hesperidin on the behavioral function and biochemical parameters were evaluated. The animals administered with hesperidin 25, 50 and 100 mg/kg did not show any significant changes in locomotor activity, grip strength, muscular strength, and biochemical parameters. Also, hesperidin improved the anxiolytic behavior in rats.

 

Throughout the study, hesperidin did not affect the body weight of the animals. Bodyweight is considered as a simple and sensitive indicator of adverse effects after exposure to asubstance.16In the experimental animals, hesperidin does not exhibit any negative effect on the growth, weight loss or weight gain of the animals.17 Thenmozhi et al., also studied the effect of hesperidin on body weight at the dose levels of 100 mg/kg body weight in rats and observed no significant changes in regular body weight. Hesperidin also prevented the metal ion-induced reduction in the body weight of experimental animals.18

 

In the present study, hesperidin did not affect the locomotor activity. Kumar et al., studied the effect of hesperidin (50 mg/ kg) on locomotor activity and observed no significant changes in locomotor activity.19Wire grip strength test has been done and it includes the functional observational battery (FOB) to study the neurobehavioral toxicity and the changes that occur in grip strength have been explained as evidence for motor neurotoxicity in experimental rats.20 Throughout the study, hesperidin did not show any changes in grip strength behavior.

 

Motor coordination is one of the complex behavioral domains which could show muscle strength, balance, and patterned gait, as well as the competence of the sensory system functions. Problems in motor performance can disconcert the behavioral pattern of learning and memory, exploration, motivation, and nociception.21 In the present study, hesperidin did not show any significant changes in muscular strength. Kumar et al., studied the effect of hesperidin on muscular function in rats and did not observe any significant changes in the grip strength when compared with vehicle administered group.19 Hesperidin also didn’t affect the immobilization time in the forced swim test. A forced swim test is used to monitor depressive-like behavior and assumes that immobility reflects a measure of behavioral despair.13Javed et al., evaluated the effect of hesperidin (100 and 200mg/kg) on the impairment of memory in an intracerebroventricular streptozotocin-induced model of memory impairment (using Morri’swatermaze test) in mice and observed memory enhancement effect.22 Hesperidin also has a beneficial effect on neuroinflammation, neurobehavioral, oxidative stress and lipid alteration in intra cerebroventricular streptozotocin-induced cognitive impairment in mice.22,23

 

Hesperidin (50 and 100 mg/kg) and vitamin C reduced time spend in closed arms and increased time spend in open arms when compared with the control. The results indicated that both hesperidin (50 and 100 mg/kg) and vitamin C administered animals had improved their normal anxiety behavior. The elevated plusma zetest which is widely used for rodent models of anxiety in research to investigate the neurochemical basis of anxiety and the psychological of the rats [24]. Fu et al., reported the antidepressant effects of hesperidin. In chronic unpredictable mild stress-induced mice, hesperidin (100, 200 mg/kg) significantly relieved depressive-like behaviors[25]. Hesperidin (100 mg/kg) also, improved continuous and interval swimming in rats.26

 

Hesperidin (25, 50 and 100 mg/kg) and vitamin C did not show any significant changes in biochemical parameters. In four weeks of continuous and interval swimming study, hesperidin lowered total cholesterol and triglycerides and increased high-density lipoprotein cholesterol.26Hesperidin is known for its antioxidant effect and this effect may contribute to its pharmacological actions.27Hesperidin is predominantly metabolized to hesperedin-7-O-β-D-glucuronide and hesperedin-3’-O-β-D-glucuronide. Both these metabolites have transactivation activity towards peroxisome proliferator-activated receptor gamma and regulates glucose and lipid homeostasis in human.28 Hesperidin also reduces inflammatory mediators including cyclooxygenase and oxide synthase and prevents/ reduces oxidative stress-induced cellular damage and improves the well-being.29,30

 

CONCLUSION:

The experimental rats administered with hesperidin at the dose levels of 25, 50 and100 mg/kg did not show any changes in psychomotor behavior such as locomotor activity, muscular strength, and immobilization time and significantly improved their alertness when compared with control. Hesperidin also did not show any significant changes in biochemical parameters at the dose levels of 25, 50 and100 mg/kg. Thus, this study results suggest that hesperidin can improve well-being (alertness) without producing any alterations in psychomotor behavior and biochemical markers of liver and kidney function.

 

REFERENCES:

1.      Parasuraman S, Perumal P. Wound Healing Agents from Natural Sources. InWound Healing Research 2021 (pp. 95-148). Springer, Singapore.doi: 10.1007/978-981-16-2677-7_4.

2.      Zhang Y, Wu L, Ma Z, Cheng J, Liu J. Anti-Diabetic, Antioxidant and anti-hyperlipidemic activities of flavonoids from corn silk on STZ-induced diabetic mice. Molecules. 2015;21(1):E7.doi: 10.3390/molecules21010007.

3.      Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47. doi: 10.1017/jns.2016.41

4.      Alanbaki AA, AL-Mayali HM, AL-Mayali HK. Ameliorative effect of Quercetin and Hesperidin on Antioxidant and Histological Changes in the Testis of Etoposide-Induced Adult Male Rats. Res J Pharm Tech 2018;11(2):564-74. doi: 10.5958/0974-360X.2018.00105.1.

5.      Xiong H, Wang J, Ran Q, Lou G, Peng C, Gan Q, et al. Hesperidin: A therapeutic agent for obesity. Drug Des Devel Ther. 2019;13:3855-66.doi: 10.2147/DDDT.S227499.

6.      Vijayprasad S, Bb G, Bb N. Effect of vitamin C on male fertility in rats subjected to forced swimming stress. J Clin Diagn Res. 2014;8(7):HC05-8.doi: 10.7860/JCDR/2014/8432.4622.

7.      Bayomy NA, Soliman GM, Abdelaziz EZ. Effect of potassium bromate on the liver of adult male albino rat and a possible protective role of vitamin c: Histological, immunohistochemical, and biochemical study. Anat Rec (Hoboken). 2016;299(9):1256-69.doi: 10.1002/ar.23386.

8.      Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009;46(6):719-30.doi: 10.1016/j.freeradbiomed.2008.

9.      Jaya Preethi P, Padmini K, Srikanth J, Lohita M, Swetha K. Screening models for CNS stimulant drugs: areview. Asian J Pharm Res. 2013;3(3):151-55.

10.   Butchbach ME, Edwards JD, Burghes AH. Abnormal motor phenotype in the SMNDelta7 mouse model of spinal muscular atrophy. Neurobiol Dis. 2007;27(2):207-19.doi: 10.1016/j.nbd.2007.04.009.

11.   Rahman H, Eswaraiah MC, Anoosha T, Nagaveni K, Manjula K. Evaluation for CNS Activities of Hexane Extract of Citrullus lanatus Seeds. Research J Pharm Tech. 2013;6(8):878-84.

12.   Jaiswal AK. Neurobehavioural effects of prenatal sodium valproate exposure in rat offspring. Res J PharmacolPharmacodyn.2016;8(3): 27-33.doi: 10.5958/2321-5836.2016.00024.0.

13.   Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015;(97):52587. doi: 10.3791/52587.

14.   Raj PV, Parasuraman S, Dhanaraj SA, Ying LX, Luc TH, Yin KC. Effect of Ganoderma lucidum on MPTP induced behavioral alterations in Swiss albino mice. J Young Pharm. 2016;8(3):194-7.doi: 10.5530/jyp.2016.3.5.

15.   Parasuraman S, Raveendran R. (2022). Biological Sample Collection from Experimental Animals. In: Lakshmanan M, Shewade DG, Raj GM. (eds) Introduction to Basics of Pharmacology and Toxicology (Volume 3). Springer, Singapore.doi: 10.1007/978-981-19-5343-9_4.

16.   Hooper L, Abdelhamid A, Moore HJ, Douthwaite W, Skeaff CM, Summerbell CD. Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ. 2012;345:e7666.doi: 10.1136/bmj.e7666.

17.   Li Y, Kandhare AD, Mukherjee AA, Bodhankar SL. Acute and sub-chronic oral toxicity studies of hesperidin isolated from orange peel extract in Sprague Dawley rats. Regul Toxicol Pharmacol. 2019;105:77-85.doi: 10.1016/j.yrtph.2019.04.001.

18.   Thenmozhi AJ, Raja TR, Janakiraman U, Manivasagam T. Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats. Neurochem Res. 2015;40(4):767-76.doi: 10.1007/s11064-015-1525-1.

19.   Kumar P, Kumar A. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res. 2010;206(1):38-46.doi: 10.1016/j.bbr.2009.08.028.

20.   Maurissen JP, Marable BR, Andrus AK, Stebbins KE. Factors affecting grip strength testing. Neurotoxicol Teratol. 2003;25(5):543-53.doi: 10.1016/s0892-0362(03)00073-4.

21.   Rustay NR, Wahlsten D, Crabbe JC. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res. 2003;141(2):237-49.

22.   Javed H, Vaibhav K, Ahmed ME, Khan A, Tabassum R, Islam F, et al. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. J Neurol Sci. 2015;348(1-2):51-9.doi: 10.1016/j.jns.2014.10.044.

23.   Al-Rikabi RH, Al-Shmgani HS. Evaluation of hesperidin protective effect on lipopolysaccharide -induced inflammation and lipid peroxidation in BALB/c male mice. Res J Pharm Tech. 2018;11(12):5369-72.doi: 10.5958/0974-360X.2018.00978.2. 

24.   Dawson GR, Tricklebank MD. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharm Sci. 1995;16(2):33-6.doi: 10.1016/s0165-6147(00)88973-7.

25.   Fu H, Liu L, Tong Y, Li Y, Zhang X, Gao X, Yong J, Zhao J, Xiao D, Wen K, Wang H. The antidepressant effects of hesperidin on chronic unpredictable mild stress-induced mice. Eur J Pharmacol. 2019;853:236-46.doi: 10.1016/j.ejphar.2019.03.035.

26.   de Oliveira DM, Dourado GK, Cesar TB. Hesperidin associated with continuous and interval swimming improved biochemical and oxidative biomarkers in rats. J Int Soc Sports Nutr. 2013;10:27.doi: 10.1186/1550-2783-10-27.

27.   Nardarajah D. Hesperidin-A short review. Res J Pharm Tech. 2014;7(1):78-80.

28.   Julius A, Vedasendiyar R, Devakannan A, Rajaraman S, Rangasamy B, Saravanan V. Effect of hesperidin for its anti-proliferative activity on liver cancer and cardiovascular diseases. Res J Pharm Tech. 2017;10(1):307-8.doi: 10.5958/0974-360X.2017.00062.2.

29.   Al-Ashaal HA, El-Sheltawy ST. Antioxidant capacity of hesperidin from citrus peel using electron spin resonance and cytotoxic activity against human carcinoma cell lines. Pharm Biol. 2011;49(3):276-82.doi: 10.3109/13880209.2010.509734.

30.   Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2015;29(3):323-31.doi: 10.1002/ptr.5256.

 

 

 

Received on 07.09.2022            Modified on 13.11.2022

Accepted on 07.01.2023           © RJPT All right reserved

Research J. Pharm. and Tech 2023; 16(8):3749-3754.

DOI: 10.52711/0974-360X.2023.00619